Randomised controlled trial of posterior sub-Tenon triamcinolone as adjunct to panretinal photocoagulation for treatment of diabetic retinopathy
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    "Authors' Response"
    Thank you for your comment. In our manuscript, we did not use the mean and the standard deviation but used each patient's raw data for the analyses. Further, as written in the methods section, we only used unpaired Student's t test (parametric test) for the comparison between the two groups and paired Student's t test (parametric test) for the comparison between the baseline and each follow-up point.

    Conflict of Interest:

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Response to RCT trial of PST as an adjuvant to PRP in Diabetic Retinopathy
    • Dr Kumar Sambhav, Vitreoretinal surgeon
    • Other Contributors:
      • Dr Kapil Bhatia M.S, Dr Padmaja Kumari Rani, M.S, FNB (Retina)

    Dear editor,

    We have read with great interest the article by Unoki N et al Randomised controlled clinical trial of sub-tenon triamcinolone as an adjunct to panretinal photocoagulation for the treatment of diabetic retinopathy 1. We wish to make few comments. The p value of the primary outcome as documented is 0.04. But if calculated from the results documented, applying parametric tests as used in the study it co...

    Show More
    Conflict of Interest:
    None declared.